The FH adults in the family showed severe clinical symptoms and statin therapy resistance.<h4>Conclusion</h4>This study identified a novel pathogenic LDLR variant, c.89_92dup, associated with severe FH clinical manifestations and statin therapy resistance. Here, LDLR is linked to familial hyperaldosteronism.